The authors describe the use of gabapentin in the treatment of 4 outpatient
s with dementia-associated agitation. On the basis of clinical case reports
and the Overt Agitation Severity Scale, all 4 patients had reduced agitati
on with gabapentin. Three of 4 patients were successfully titrated to a ful
l nose of 2,400mg/day. These findings suggest a possible role for gabapenti
n in the behavioral management of patients with dementia.